Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7

MT NewswiresNov 15 01:56 · Ratings

Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 12 21:33 · Ratings

IntegriChain Revenue Optimization Experts to Speak at Informa's Pharma/BioTech GTN Summit

PR NewswireNov 11 22:14

MannKind's Growth Momentum and Increased Confidence in Pipeline Elevate Buy Rating

TipRanksNov 11 14:25 · Ratings

Q3 2024 MannKind Corp Earnings Call

Yahoo FinanceNov 9 02:26

RBC Capital Sticks to Its Hold Rating for MannKind (MNKD)

TipRanksNov 8 20:05 · Ratings